APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 260 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 2.08 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $206,494 | -1.8% | 3,513 | 0.0% | 0.00% | -25.0% |
Q4 2023 | $210,288 | -15.1% | 3,513 | +29.2% | 0.00% | -20.0% |
Q2 2023 | $247,792 | -2.5% | 2,720 | -29.4% | 0.01% | -16.7% |
Q1 2023 | $254,078 | -16.4% | 3,852 | -13.6% | 0.01% | -33.3% |
Q3 2022 | $304,000 | – | 4,458 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AJU IB Investment Co., Ltd. | 624,962 | $20,599,000 | 13.29% |
Octagon Capital Advisors LP | 1,595,911 | $52,601,000 | 12.95% |
Logos Global Management LP | 1,450,000 | $47,792,000 | 3.45% |
Avoro Capital Advisors LLC | 5,000,000 | $164,800,000 | 2.59% |
Ghost Tree Capital, LLC | 200,000 | $6,592,000 | 1.93% |
Integral Health Asset Management, LLC | 190,000 | $6,262,000 | 1.80% |
GREAT POINT PARTNERS LLC | 200,000 | $6,592,000 | 1.54% |
Aufman Associates Inc | 53,642 | $1,768,000 | 1.45% |
Ghost Tree Capital, LLC | 150,000 | $4,944,000 | 1.45% |
Altium Capital Management LP | 166,700 | $5,494,000 | 1.44% |